Organigram Holdings Inc. EV/Sales

EV/Sales of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/Sales growth rates and interactive chart. Compares the total enterprise value of a company to its sales. It is a more accurate measure of business value, as it takes into account cash and debt on the balance sheet. A company with large cash holdings and no debt will show a significantly lower EV/S than P/S ratio.

Highlights and Quick Summary

Current EV/Sales of Organigram Holdings Inc. is 10.45 (as of August 31, 2021)
  • EV/Sales for the quarter ending February 28, 2022 was 4.07 (a -39.93% decrease compared to previous quarter)
  • Year-over-year quarterly EV/Sales decreased by -65.7%
  • Annual EV/Sales for 2021 was 10.45 (a 172.45% increase from previous year)
  • Annual EV/Sales for 2020 was 3.84 (a -61.68% decrease from previous year)
  • Annual EV/Sales for 2019 was 10.01 (a Infinity% increase from previous year)
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/Sales of Organigram Holdings Inc.

Most recent EV/Salesof OGI including historical data for past 10 years.

Interactive Chart of EV/Sales of Organigram Holdings Inc.

Organigram Holdings Inc. EV/Sales for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 4.07 – – – –
2021 6.77 10.45 11.85 13.4 10.45
2020 4.5 3.84 5.62 6.07 3.84
2019 6.53 10.01 20.82 0.0 10.01
2018 – – 0.0 0.0 0.0
2017 – – – – 0.0
2016 – – – – 0.0

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com